Financials
Financial year 2025
BF Resp Oncology from Overijse, company number BE1013959311, closed financial year 2025 with a result of € 317,166 after tax. For that financial year BF Resp Oncology recorded a gross margin of € 422,084 and equity of € 319,166. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 25, 2026.
€ 319,166
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 317,166
Profit after tax over the fiscal year.
€ 204,857
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 317,166.
People and assets in 2025
€ 2,860
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,044
Supplier invoices still open on the last day of the fiscal year.
€ 103,109
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about BF Resp Oncology the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to BF Resp Oncology?
What happened at BF Resp Oncology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 317,166. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Halle. KBO
In short
Paid € 103,109 in corporate taxes since 2025.
Management
Behind BF Resp Oncology is Bart Jos Forier.
Directors
According to the 2025 annual accounts
Bart Jos Forier
Director
Establishments
Establishment units
Physical locations of this company
Schapenweg 68
3090 Overijse
Ziekenhuislaan 100
1500 Halle
Active since 23 September 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Overijse
Same main activity (Activiteiten van medisch specialisten), 34 active companies in Overijse, largest first.
€ 1.9 million gross margin · 2025
DR. TESSA DE WANDELER RADIOLOGIE
€ 507,953 gross margin · 2025
€ 384,143 gross margin · 2025
€ 334,553 gross margin · 2025
€ 293,636 gross margin · 2025
€ 278,698 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- FORIER Bart Jos Frans(oprichter) 100%
Details
- Company number
- 1013.959.311
- VAT number
- BE 1013.959.311
- Registered office
- Schapenweg 68, 3090 Overijse
- Names & denominations
- BF Resp Oncology
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 September 2024
- Peppol
- Active · Active since 2 Sept 2025
- Activities · NACE
Activiteiten van medisch specialisten